Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sunshine Biopharma Inc.

1.55
-0.0400-2.52%
Post-market: 1.560.0100+0.65%19:35 EDT
Volume:69.48K
Turnover:108.61K
Market Cap:7.06M
PE:-0.21
High:1.59
Open:1.57
Low:1.53
Close:1.59
Loading ...
Feb 09, 2022

Correspondence

CORRESP [Cover] - Correspondence
Feb 09, 2022

Correspondence

CORRESP [Cover] - Correspondence
Feb 09, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Feb 08, 2022

Major Issues Report

8-K - Current report
Feb 03, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jan 24, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Dec 22, 2021

Major Issues Report

8-K - Current report
Nov 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2021

Major Issues Report

8-K - Current report
Sep 09, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 29, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 30, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 19, 2020

Major Issues Report

8-K - Current report
Sep 15, 2020

Major Issues Report

8-K - Current report
Aug 31, 2020

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
Aug 19, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 24, 2020

Major Issues Report

8-K - Current report